The DiaSorin LIAISON® XL is a fully automated immunoassay analyser designed for high-throughput laboratories aiming to maximize productivity while ensuring reliable and reproducible results. Utilizing chemiluminescent immunoassay (CLIA) technology, the LIAISON® XL performs immunoassays for multiple analytes in human serum or plasma, using either the "sandwich" or competition method depending on the test. This versatile platform is ideal for a broad range of diagnostic tests, including those in endocrinology, infectious diseases, autoimmunity, and oncology, making it a valuable asset for comprehensive diagnostic and research applications.

Strengths of the LIAISON® XL:

• Advanced CLIA Technology: The LIAISON® XL employs cutting-edge chemiluminescent immunoassay (CLIA) technology, offering high sensitivity and specificity in biomarker detection. This ensures highly precise results for a wide array of clinical tests.
• High Throughput Capacity: With the ability to process up to 180 tests per hour, the LIAISON® XL is designed to meet the demands of high-volume laboratories. It manages multiple tests simultaneously, optimizing workflow efficiency.
• Complete Automation: The system is fully automated, covering all steps from sample preparation to result generation. This minimizes human intervention, reducing errors and enhancing test reproducibility.
• Flexibility and Versatility: The LIAISON® XL supports a broad range of tests across various medical disciplines, including infectious diseases, oncology, thyroid disorders, and autoimmunity. It also accommodates urgent stat tests without disrupting ongoing analyses.

Clinical Applications: The LIAISON® XL is used for a diverse range of diagnostic tests, from tumor markers and infectious diseases to hormones, vitamins, and autoimmunity-related tests. It is particularly well-suited for environments requiring rapid results, such as emergency settings, specialized laboratories, and reference centers.